Consolidated Statements of Operations and Comprehensive Earnings and Loss - USD ($) shares in Thousands, $ in Thousands	12 Months Ended
	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2015
Income Statement [Abstract]
Operating revenues (net of contractual allowances)	$ 53,766	$ 64,871	$ 77,424
Less provision for bad debts of Healthcare Services segment	478	1,438	3,678
Net Revenues	53,288	63,433	73,746
Costs and expenses:
Cost of goods sold	19,917	20,404	21,042
Salaries, wages and benefits	23,378	30,783	33,620
Provision for bad debts of Pharmacy segment	438	630	363
Supplies	1,844	3,326	4,366
Purchased services	2,767	3,248	3,616
Other operating expenses	5,616	8,031	6,893
Rents and leases expense	561	791	818
Impairments	1,427	858	0
Insurance settlement	0	0	(1,000)
Depreciation and amortization	1,914	1,878	1,837
Electronic Health Records incentive payments	(64)	7	(29)
Operating profit (loss)	(4,510)	(6,523)	2,220
Other income (expense):
Interest expense	(635)	(843)	(861)
Loss on extinguishment of debt-net	(243)	0	0
Gain (loss) on sale of assets	2,917	10	21
Earnings (Loss) from continuing operations before income taxes	(2,471)	(7,356)	1,380
Income tax (benefit) expense	(512)	4,558	893
Earnings (loss) from continuing operations	(1,959)	(11,914)	487
Earnings (loss) from discontinued operations, net of income taxes	4,647	(2,169)	(242)
Net earnings (loss)	2,688	(14,083)	245
Other comprehensive income (loss)	93	(46)	(40)
Comprehensive income (loss)	$ 2,781	$ (14,129)	$ 205
Continuing operations:
Basic	$ (0.21)	$ (1.26)	$ 0.05
Diluted	(0.21)	(1.26)	0.05
Discontinued operations:
Basic	0.50	(0.23)	(0.02)
Diluted	0.50	(0.23)	(0.02)
Net earnings (loss):
Basic	0.29	(1.49)	0.03
Diluted	$ 0.29	$ (1.49)	$ 0.03
Weighted-average common shares outstanding:
Basic	9,346	9,443	9,443
Diluted	9,346	9,443	9,496